Bill Title: Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agent approved by the federal food and drug administration; allows for choice of any formulation and dosage of opioid reversal agent approved by the federal food and drug administration in the purchase, distribution or authorization to prescribe or dispense such products and in any expenditure used for the purchase or distribution of an opioid reversal agent.

Spectrum: Slight Partisan Bill (Democrat 10-5)

Status: (Introduced) 2024-04-09 - reported referred to ways and means [A08075 Detail]

---

Bill Drafts

Revision	Date	Format	Source	View
Amended	2023-09-27	HTML/Text	Link	View
Amended	2023-09-27	HTML/Text	Link	View
Amended	2023-09-27	HTML/Text	Link	View
Introduced	2023-09-27	HTML/Text	Link	View

Amendments

Amendment	Date	Disposition	Format	Source	View
No bill amendments currently on file for New York A08075

Supplemental Documents

Title	Description	Date	Format	Source	View
No supplemental documents for New York A08075 currently on file.

Social Comments on NY A08075